If you have diabetes, especially type 2 and you're over 65, your brain health belongs on the agenda at your next appointment — starting with a request for a cognitive screening and a review of your blood sugar targets. The connection is well documented: NIH-indexed reviews estimate roughly 60% greater risk of cognitive decline in type 2 diabetes, and about double the dementia risk in older adults with diabetes compared with the general population. The good news is that guidelines now spell out exactly what care you should expect, which gives you concrete questions to bring to your doctor. This article walks through the most useful ones: when to be screened, what blood sugar target is safest for your brain, whether your medications matter, and what to change if memory problems have already appeared.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Should I be screened for memory problems — and how often?
- What A1C target is right for my brain?
- Do my diabetes medications affect dementia risk?
- What should change if memory problems are already showing?
- What can I do between appointments?
- Frequently Asked Questions
Should I be screened for memory problems — and how often?
This is the first question to ask, because there is now a clear standard. The American Diabetes Association's Standards of Care in Diabetes—2026 recommends screening adults with diabetes aged 65 or older for mild cognitive impairment or dementia at the initial visit, annually, and whenever concerns arise. If you or a family member is 65 or older with diabetes and has never had a cognitive check, you can ask for one by name.
The screening itself is brief and done in the office. The ADA lists the Mini-Cog, the Mini-Mental State Examination (MMSE), and the Montreal Cognitive Assessment (MoCA) as acceptable tools. These take a few minutes and involve tasks like recalling words and drawing a clock face — no lab work or imaging required for the initial screen. Useful phrasings for the appointment:.
- "Can we do a Mini-Cog or MoCA today, and repeat it each year?"
- "What score would prompt a fuller evaluation?"
- "Should my caregiver or spouse be part of this conversation?"
What A1C target is right for my brain?
A1C — the blood test that reflects average blood sugar over about three months — is not a case of "lower is always better" when it comes to cognition. According to the ADA Standards of Care, both very high A1C (above 9%) and excessively low A1C have been associated with increased cognitive impairment risk in adults over 45 with type 2 diabetes. The right question is not "how do I get my number as low as possible" but "what individualized target balances control against hypoglycemia risk for me?" The reason both extremes matter comes down to blood vessels. The CDC explains that both high and low blood sugar can damage the blood vessels in the brain, and reduced blood flow can kill brain cells — causing memory and thinking problems that can progress to vascular dementia.
Hypoglycemia deserves its own line of questioning. A 2025 meta-analysis indexed by NIH/PMC found severe hypoglycemic episodes linked to 49% higher all-cause dementia risk and 31% higher Alzheimer's risk. The relationship runs both ways: existing cognitive impairment also raises the risk of future hypoglycemia, because remembering doses and recognizing warning symptoms gets harder. If you've had even one severe low, tell your doctor and ask whether your regimen should change.
Do my diabetes medications affect dementia risk?
Possibly — and it's a fair question to raise, with realistic expectations. The largest study of its kind, published in BMJ Open diabetes Research & Care in 2025 and summarized by BMJ Group, found that people taking GLP-1 receptor agonists had roughly a 2.5% ten-year dementia incidence versus nearly 5% among metformin users. Separate meta-analyses associate SGLT2 inhibitors with reduced incident dementia as well.
The critical caveat: these findings come from observational studies, not definitive randomized trials. As a commentary in BMJ Open Diabetes Research & Care notes, they show association rather than proven prevention, and no diabetes drug is approved to prevent dementia. People prescribed newer drugs may differ in ways that also affect dementia risk. So the question to ask isn't "should I switch to protect my brain" — it's "given my heart, kidney, weight, and cognitive picture, is a GLP-1 or SGLT2 inhibitor a reasonable fit for my diabetes overall?" Brain-health signals are one factor among several, not a stand-alone reason to change a regimen that's working.
What should change if memory problems are already showing?
If screening finds impairment, or a family member has noticed changes, the guidance shifts from monitoring to simplifying. The ADA advises that when cognitive impairment is present, the diabetes treatment plan should be simplified and tailored to minimize hypoglycemia risk.
A complicated regimen — multiple daily injections, sliding scales, tight targets — becomes actively dangerous when doses get missed or doubled. Questions worth asking at this stage: Caregivers should be in the room for this conversation if possible, since they often administer or supervise medications. The goal is a plan the household can actually execute safely, not the tightest control on paper.
- Can we reduce the number of daily medications or doses?
- Can we replace drugs that cause lows (like sulfonylureas or complex insulin schedules) with lower-risk options?
- Should my A1C target be relaxed, and to what number?
- What should my caregiver watch for as signs of low blood sugar?
What can I do between appointments?
The modifiable-risk list for brain health with diabetes overlaps heavily with standard diabetes self-care, which means the effort does double duty. The CDC's brain-and-diabetes guidance endorses keeping blood sugar in your target range, controlling blood pressure and cholesterol, getting regular physical activity, not smoking, and taking medications as prescribed.
None of these requires a specialist, but each is worth a status check at your visit: ask what your blood pressure and cholesterol numbers are, whether they're at goal, and what "in range" means for your glucose specifically. If keeping track of medications is becoming a struggle, say so plainly — that difficulty is itself clinically useful information, and it may be the earliest signal that triggers the cognitive screening and regimen simplification described above.
Frequently Asked Questions
At what age should cognitive screening start for people with diabetes?
The ADA recommends screening at 65 and older — at the first visit, then annually, and sooner if you or family notice changes.
Does having diabetes mean I will develop dementia?
No. Risk is roughly doubled in older adults with diabetes, but most people with diabetes do not develop dementia, and blood sugar, blood pressure, and lifestyle management all reduce risk.
Is low blood sugar really worse for the brain than high blood sugar?
Both are harmful. Severe hypoglycemia is linked to 49% higher dementia risk in meta-analysis data, while A1C above 9% is also associated with cognitive impairment — which is why targets should be individualized.
